These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 26240324)

  • 1. Ubiquitination by March-I prevents MHC class II recycling and promotes MHC class II turnover in antigen-presenting cells.
    Cho KJ; Walseng E; Ishido S; Roche PA
    Proc Natl Acad Sci U S A; 2015 Aug; 112(33):10449-54. PubMed ID: 26240324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitination regulates MHC class II-peptide complex retention and degradation in dendritic cells.
    Walseng E; Furuta K; Bosch B; Weih KA; Matsuki Y; Bakke O; Ishido S; Roche PA
    Proc Natl Acad Sci U S A; 2010 Nov; 107(47):20465-70. PubMed ID: 21059907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubiquitination of MHC Class II by March-I Regulates Dendritic Cell Fitness.
    Kim HJ; Bandola-Simon J; Ishido S; Wong NW; Koparde VN; Cam M; Roche PA
    J Immunol; 2021 Feb; 206(3):494-504. PubMed ID: 33318291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A major isoform of the E3 ubiquitin ligase March-I in antigen-presenting cells has regulatory sequences within its gene.
    Kaul S; Mittal SK; Roche PA
    J Biol Chem; 2018 Mar; 293(12):4478-4485. PubMed ID: 29378848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of MHC II ubiquitination inhibits the activation and differentiation of CD4 T cells.
    Ishikawa R; Kajikawa M; Ishido S
    Int Immunol; 2014 May; 26(5):283-9. PubMed ID: 24370470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Encounter with antigen-specific primed CD4 T cells promotes MHC class II degradation in dendritic cells.
    Furuta K; Ishido S; Roche PA
    Proc Natl Acad Sci U S A; 2012 Nov; 109(47):19380-5. PubMed ID: 23129633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells.
    Young LJ; Wilson NS; Schnorrer P; Proietto A; ten Broeke T; Matsuki Y; Mount AM; Belz GT; O'Keeffe M; Ohmura-Hoshino M; Ishido S; Stoorvogel W; Heath WR; Shortman K; Villadangos JA
    Nat Immunol; 2008 Nov; 9(11):1244-52. PubMed ID: 18849989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-specific CD4+ T cells are activated by "cross-dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines.
    Dolan BP; Gibbs KD; Ostrand-Rosenberg S
    J Immunol; 2006 Feb; 176(3):1447-55. PubMed ID: 16424172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 10 (IL-10)-mediated Immunosuppression: MARCH-I INDUCTION REGULATES ANTIGEN PRESENTATION BY MACROPHAGES BUT NOT DENDRITIC CELLS.
    Mittal SK; Cho KJ; Ishido S; Roche PA
    J Biol Chem; 2015 Nov; 290(45):27158-27167. PubMed ID: 26408197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MARCH1-mediated ubiquitination of MHC II impacts the MHC I antigen presentation pathway.
    Wilson KR; Liu H; Healey G; Vuong V; Ishido S; Herold MJ; Villadangos JA; Mintern JD
    PLoS One; 2018; 13(7):e0200540. PubMed ID: 30001419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Internalizing MHC class II-peptide complexes are ubiquitinated in early endosomes and targeted for lysosomal degradation.
    Furuta K; Walseng E; Roche PA
    Proc Natl Acad Sci U S A; 2013 Dec; 110(50):20188-93. PubMed ID: 24277838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of Dendritic Cells Alters the Mechanism of MHC Class II Antigen Presentation to CD4 T Cells.
    Cho KJ; Ishido S; Eisenlohr LC; Roche PA
    J Immunol; 2020 Mar; 204(6):1621-1629. PubMed ID: 31996461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitin ligase MARCH 8 cooperates with CD83 to control surface MHC II expression in thymic epithelium and CD4 T cell selection.
    Liu H; Jain R; Guan J; Vuong V; Ishido S; La Gruta NL; Gray DH; Villadangos JA; Mintern JD
    J Exp Med; 2016 Aug; 213(9):1695-703. PubMed ID: 27503069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major histocompatibility complex (MHC) class II-peptide complexes arrive at the plasma membrane in cholesterol-rich microclusters.
    Bosch B; Heipertz EL; Drake JR; Roche PA
    J Biol Chem; 2013 May; 288(19):13236-42. PubMed ID: 23532855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cells regulate exposure of MHC class II at their plasma membrane by oligoubiquitination.
    van Niel G; Wubbolts R; Ten Broeke T; Buschow SI; Ossendorp FA; Melief CJ; Raposo G; van Balkom BW; Stoorvogel W
    Immunity; 2006 Dec; 25(6):885-94. PubMed ID: 17174123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hrd1-mediated BLIMP-1 ubiquitination promotes dendritic cell MHCII expression for CD4 T cell priming during inflammation.
    Yang H; Qiu Q; Gao B; Kong S; Lin Z; Fang D
    J Exp Med; 2014 Nov; 211(12):2467-79. PubMed ID: 25366967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutting edge: requirement of MARCH-I-mediated MHC II ubiquitination for the maintenance of conventional dendritic cells.
    Ohmura-Hoshino M; Matsuki Y; Mito-Yoshida M; Goto E; Aoki-Kawasumi M; Nakayama M; Ohara O; Ishido S
    J Immunol; 2009 Dec; 183(11):6893-7. PubMed ID: 19917682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MHC II in dendritic cells is targeted to lysosomes or T cell-induced exosomes via distinct multivesicular body pathways.
    Buschow SI; Nolte-'t Hoen EN; van Niel G; Pols MS; ten Broeke T; Lauwen M; Ossendorp F; Melief CJ; Raposo G; Wubbolts R; Wauben MH; Stoorvogel W
    Traffic; 2009 Oct; 10(10):1528-42. PubMed ID: 19682328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of MHC class II and CD86 expression by March-I in immunity and disease.
    Bandola-Simon J; Roche PA
    Curr Opin Immunol; 2023 Jun; 82():102325. PubMed ID: 37075597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major histocompatibility complex class II-peptide complexes internalize using a clathrin- and dynamin-independent endocytosis pathway.
    Walseng E; Bakke O; Roche PA
    J Biol Chem; 2008 May; 283(21):14717-27. PubMed ID: 18378669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.